Nwam LLC Edwards Lifesciences Corp Transaction History

Nwam LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$72.54 - $95.56 $362 - $477	5 Added 0.05%	10,580 $1.01 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $3,764 - $4,743	-61 Reduced 0.57%	10,575 $806,000
Q3 2023 Oct 31, 2023	SELL	$69.28 - $93.38 $9,907 - $13,353	-143 Reduced 1.33%	10,636 $736,000
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $33,866 - $39,241	-416 Reduced 3.72%	10,779 $1.02 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $1,113 - $1,267	15 Added 0.13%	11,195 $926,000
Q4 2022 Feb 07, 2023	SELL	$68.3 - $87.44 $4,234 - $5,421	-62 Reduced 0.55%	11,180 $834,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $24,134 - $31,435	293 Added 2.68%	11,242 $929,000
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $351,103 - $520,647	-4,059 Reduced 27.05%	10,949 $1.07 Million
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $1.1 Million - $1.38 Million	10,790 Added 255.81%	15,008 $1.77 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $114,773 - $141,003	1,079 Added 34.37%	4,218 $546,000
Q3 2021 Nov 03, 2021	BUY	$102.91 - $122.75 $323,034 - $385,312	3,139 New	3,139 $355,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

Stay updated on Nwam LLC with notifications on news.